Marta
Llanos Muñoz
Part Time Assistant Professor (Health Science)


Hospital Costa Del Sol
Marbella, EspañaPublications in collaboration with researchers from Hospital Costa Del Sol (12)
2019
-
Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
Leukemia and Lymphoma
-
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group
Leukemia and Lymphoma
-
Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group
Hematological Oncology, Vol. 37, Núm. 2, pp. 143-150
-
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
PLoS ONE, Vol. 14, Núm. 2
2017
2015
-
SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1005-1013
-
SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1014-1019
2014
-
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group
Leukemia and Lymphoma, Vol. 55, Núm. 1, pp. 51-55
-
High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma
Leukemia and Lymphoma
-
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
Haematologica
2010
-
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 760-764
2004
-
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: Results after 7 years of a prospective study
Annals of Oncology, Vol. 15, Núm. 12, pp. 1798-1804